Trajan Group Holdings Limited (ASX:TRJ)

Market Cap	99.15M -36.2%
Revenue (ttm)	166.46M +7.4%
Net Income	-4.46M
EPS	-0.03
Shares Out	152.54M
PE Ratio	n/a
Forward PE	23.21
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,513
Average Volume	35,758
Open	0.6550
Previous Close	0.6450
Day's Range	0.6500 - 0.6550
52-Week Range	0.6250 - 0.9950
Beta	0.48
RSI	44.40
Earnings Date	Feb 26, 2026

About Trajan Group Holdings

Trajan Group Holdings Limited develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including syringes, GC columns and septa, inlet liners, rings, and tubing products; and sampling products, comprising septa, caps, liners, well plates and sealing mats, crimping tools, and micro sampling tools, as well as automation systems and consumables. It also provides pathology produ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Employees: 650
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: TRJ

Financial Performance

In fiscal year 2025, Trajan Group Holdings's revenue was 166.46 million, an increase of 7.38% compared to the previous year's 155.02 million. Losses were -4.46 million, -82.39% less than in 2024.